Stockscreener 앱 받기
158.36
6.02%
-10.14
시장 영업 전:
160.98
2.62
+1.65%
전일 마감가:
$168.50
열려 있는:
$168.92
하루 거래량:
2.23M
Relative Volume:
1.84
시가총액:
$19.45B
수익:
$1.53B
순이익/손실:
$-214.69M
주가수익비율:
-89.98
EPS:
-1.76
순현금흐름:
$-43.68M
1주 성능:
-9.51%
1개월 성능:
-5.86%
6개월 성능:
+43.48%
1년 성능:
+134.61%
1일 변동 폭
$157.51
$169.55
1주일 범위
$157.51
$183.00
52주 변동 폭
$62.96
$183.00
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
158.36 | 19.45B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Guardant Health: Remains Risky Despite SHIELD’s Early Success (NASDAQ:GH) - Seeking Alpha
Sheena Jonathan Natera Stock Sale Highlights Insider Confidence Amid Legal and Financial Milestones - HPBL
Looking Into Natera's Recent Short Interest - Benzinga
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Artemis Investment Management LLP - MarketBeat
Avanza Fonder AB Takes $1.02 Million Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 2.8%Here's Why - MarketBeat
Natera guides Q4 and FY revenue above consensus - MSN
Natera (NASDAQ:NTRA) Price Target Raised to $200.00 at Guggenheim - MarketBeat
Wall Street Analysts Adjust Price Targets: Key Changes for Morgan Stanley, Bank of America, Natera and More - HPBL
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - BioSpace
Natera CEO Steve Chapman Named BioTech Innovator of the Year, Leads 20 Product Launches - StockTitan
Analysts reset Natera stock price target by 20% - TheStreet
Rockingstone Advisors LLC Buys Shares of 16,326 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Assenagon Asset Management S.A. Has $51.47 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera’s Bold Moves Stir Up Stock Market Buzz - TipRanks
Natera reports on robust product pipeline at JPM - BioWorld Online
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection - BioSpace
Natera Unveils Revolutionary Cancer Detection Tech with 92% Early-Stage Accuracy - StockTitan
Natera (NASDAQ:NTRA) Reaches New 12-Month HighTime to Buy? - MarketBeat
Natera (NASDAQ:NTRA) Shares Gap Up After Analyst Upgrade - MarketBeat
Why Natera Stocks Are Gaining Attention - TipRanks
Non-Invasive Prenatal Testing Market Top Companies Study - openPR
Natera Shatters Growth Records: Q4 Revenue Surges 52% to $472M, Oncology Tests Jump 55% - StockTitan
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024 - Business Wire
Insider Sell Alert: Daniel Rabinowitz Sells 6,223 Shares of Nate - GuruFocus.com
Harbor Capital Advisors Inc. Trims Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera's chief legal officer sells $1.09 million in stock - Investing.com India
Natera’s chief legal officer sells $1.09 million in stock By Investing.com - Investing.com Nigeria
The Analyst Verdict: Natera In The Eyes Of 14 Experts - Benzinga
Sanford C. Bernstein Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price - MarketBeat
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings - The Motley Fool
Natera, Inc. (NASDAQ:NTRA) Shares Sold by First Hawaiian Bank - MarketBeat
Natera Stock Soars to All-Time High of $175.68 By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Reaches New 1-Year HighShould You Buy? - MarketBeat
Natera Stock Soars to All-Time High of $175.68 - Investing.com India
Natera nabs ADLT status - LabPulse
Ravgen wins $57M in patent infringement suit against Natera - LabPulse
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
3,984 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Silverleafe Capital Partners LLC - MarketBeat
Natera Fails to Expand $96 Million Patent Win Over CareDx (1) - Bloomberg Law
(NTRA) Technical Data - Stock Traders Daily
Everence Capital Management Inc. Acquires Shares of 3,620 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Everence Capital Management Inc. Makes New $573,000 Investment in Natera, Inc. (NASDAQ:NTRA) - Defense World
Natera co-founder Sheena Jonathan sells $909k in stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $909k in stock - Investing.com
Natera Loses New Trial Bid After Winning $96M Patent Verdict - Law360
Undercovered Dozen: Natera, Lloyds Banking Group, Eaton, Primoris Services + - Seeking Alpha
Canaccord Genuity Group Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
자본화:
|
볼륨(24시간):